Brokerage firm, Indiabulls Financial Services, denied media reports hinting their participation in any fake trading or price fixing in the futures & options (F&O) segment.
According to a company release that Indiabulls Securities or any of its group companies have not been concerned in any counterfeit trading or price fixing in F&O division and have not traded directly or indirectly on its own account in the 23 trades on the F&O segment as mentioned in the SEBI order.
After annunciating that it had received USFDA nod for antibiotic Cefprozil tablets, Wockhardt shares climbed up to Rs 395.10.
The shares touched a high of Rs 399 and a low of Rs 391.85 during the day. About 50486 shares were traded on BSE. In the last one quarter, the scrip had an average daily volume of 33,390 shares.